Financials & Filings Show all 2023 First Quarter Revance Therapeutics 2023 First Quarter Financial Results Revance Reports First Quarter 2023 Financial Results, Provides Corporate Update Form 10-Q 2022 Fourth Quarter Revance Therapeutics 2022 Fourth Quarter Financial Results Revance Reports Fourth Quarter and Full Year 2022 Financial Results, Provides Corporate Update Form 10-K Third Quarter Revance Therapeutics 2022 Third Quarter Financial Results Revance Reports Third Quarter 2022 Financial Results, Provides Corporate Update Form 10-Q Second Quarter Revance Therapeutics 2022 Second Quarter Financial Results Revance Reports Second Quarter 2022 Financial Results, Provides Corporate Update Form 10-Q First Quarter Revance Therapeutics 2022 First Quarter Financial Results Revance Reports First Quarter 2022 Financial Results, Provides Corporate Update Form 10-Q 2021 Fourth Quarter Revance Therapeutics 2021 Fourth Quarter Financial Results Revance Reports Fourth Quarter and Full Year 2021 Financial Results, Provides Corporate Update Form 10-K Third Quarter Revance Therapeutics 2021 Third Quarter Financial Results Revance Reports Third Quarter 2021 Financial Results, Provides Corporate Update Form 10-Q Second Quarter Revance Therapeutics 2021 Second Quarter Financial Results Revance Reports Second Quarter 2021 Financial Results, Provides Corporate Update Form 10-Q First Quarter Revance Therapeutics 2021 First Quarter Financial Results Revance Reports First Quarter 2021 Financial Results, Provides Corporate Update Form 10-Q 2020 Fourth Quarter Revance Therapeutics 2020 Fourth Quarter Financial Results Revance Reports Fourth Quarter and Full Year 2020 Financial Results Form 10-K Third Quarter Revance Therapeutics 2020 Third Quarter Financial Results Revance Reports Third Quarter 2020 Financial Results and Provides Corporate Update Form 10-Q Second Quarter Revance Reports Second Quarter 2020 Financial Results, Provides Corporate Update Form 10-Q First Quarter Revance Reports First Quarter 2020 Financial Results, Provides Corporate Update Form 10-Q Proxy Statements Filing date View March 23, 2023 View HTML 0001479290-23-000050.pdf 0001479290-23-000050.xls March 23, 2023 View HTML 0001479290-23-000049.pdf 0001479290-23-000049.xls Form 10-K Filing date View February 28, 2023 View HTML 0001479290-23-000028.pdf 0001479290-23-000028.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA February 28, 2022 View HTML 0001479290-22-000034.pdf 0001479290-22-000034.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA Form 10-Q Filing date View May 09, 2023 View HTML 0001479290-23-000072.pdf 0001479290-23-000072.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA November 08, 2022 View HTML 0001479290-22-000102.pdf 0001479290-22-000102.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View All SEC Filings Click Here Data provided by Kaleidoscope.
